Placenta protein may hold clues to preeclampsia
NCT ID NCT06668545
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study investigated levels of a protein called CD71 in placentas from 39 women with preeclampsia and 39 healthy pregnant women. Researchers also looked at newborn outcomes. The goal was to better understand how preeclampsia develops. No treatment was tested; this is a knowledge-gathering study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify new biomarkers for preeclampsia, potentially leading to earlier diagnosis or better management.
- What could go wrong
- This is a small, completed observational study (39 participants) that only looks at tissue samples. It does not test any treatment, so any practical benefits are far off and uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLACENTA DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kemal Sarsmaz
Manisa, Yunusemre, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a placental protein unlock the mystery of preeclampsia?
- Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
- Vitamin d may cut risk of repeat preeclampsia in High-Risk pregnancies
- Depression drug may mend blood vessels damaged by preeclampsia
- Postpartum blood pressure control may stop preeclampsia from leading to lifelong hypertension
- Genetic clues to severe preeclampsia could transform early detection